Patents
Literature
Patsnap Eureka AI that helps you search prior art, draft patents, and assess FTO risks, powered by patent and scientific literature data.

4 results about "Levetiracetam" patented technology

Levetiracetam is used with other medications to treat seizures (epilepsy).

Multi-compartment nanoemulsion for intranasal drug delivery

A method of intranasal drug delivery including administering a multi-compartment nanoemulsion to a nasal cavity of a subject in need thereof, where the multi-compartment nanoemulsion includes a water-in-oil core emulsion having an oil phase encompassing a first aqueous phase, the oil phase comprising a first surfactant and a fatty acid and the first aqueous phase comprising levetiracetam and valproic acid dissolved therein. The multi-compartment nanoemulsion further includes a second aqueous phase encompassing the water-in-oil core emulsion, the second aqueous phase comprising a second surfactant and a co-surfactant in a ratio of the second surfactant to the co-surfactant of 1:4 to 4:1. The multi-compartment nanoemulsion has an average droplet size of less than 100 nm and a polydispersity index (PDI) of 0.1 to 0.2.
Owner:KING ABDULAZIZ UNIV

An orodispersible tablet of levetiracetam and its process of preparation

The present invention relates to a solid pharmaceutical composition manufactured by a wet granulation method comprising levetiracetam or pharmaceutically acceptable salts thereof, at least one or more disintegrant, at least one or more diluent, at least one binder, at least one glidant, at least one lubricant, and one or more pharmaceutically acceptable excipients. The orodispersible tablet prepared using these excipients exhibits desirable properties such as facilitating disintegration, and dissolution of the drug for oral administration. Further, the present invention also relates to the process for preparing the said solid pharmaceutical composition.
Owner:NOVUMGEN LTD

Levetiracetam for use in the treatment of pain caused by hydrocephalus

PCT designated stageWO2026099901A1Organic active ingredientsBlood disorderHydrocephalusPharmacology
Levetiracetam is described for use in the treatment of hydrocephalus and the pain caused by it.
Owner:UNIVERSITY OF FLORENCE

A dry compression equipment for levetiracetam tablets

The utility model relates to tableting drying technical field, concretely relates to a kind of levetiracetam tabletting drying equipment, including hopper, discharging assembly, tableting assembly and drying assembly;Discharging assembly, be arranged in the below of the hopper, for the levetiracetam tablet powder falling inside the hopper above and pass to the tableting assembly below;Tableting assembly, be arranged in the below of the discharging assembly, for the tablet powder falling of discharging assembly above and powder are quantitatively distributed while being pressed into tablet;Drying assembly, be arranged in the below of the tableting assembly, for the levetiracetam tablet of pressing into shape and carry out drying work.Just compared with prior art, the present application solves the problem of uneven powder material discharging and powder accumulation in the tabletting process in the prior art.
Owner:宝利化(南京)制药有限公司